Sophora flavescens root Completed Phase N/A Trials for Severe Adverse Reactions / Adverse Drug Reaction (ADR) / Severe Adverse Events / Safety Surveillance

Indications	Status	Purpose	Phase
DBCOND0072400 (Severe Adverse Reactions) DBCOND0036209 (Adverse Drug Reaction (ADR)) DBCOND0072399 (Severe Adverse Events) DBCOND0072401 (Safety Surveillance)	Completed	Not Available	Not Available

clinicaltrials.gov Identifier	Title	Drugs
NCT02239237	Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study	Sophora flavescens root (DB14565)